Satsuma Pharmaceuticals Inc, which is focused on treating migraines, has raised $12 million Series in A financing. RA Capital Management and TPG Biotech led the round. In conjunction with the funding, Rajeev Shah, RA Capital portfolio manager and managing director and Dr. Heath Lukatch, TPG Biotech partner and managing director, have been added to Satsuma's board of directors.
1 min read · 06 January 2017
GRAIL, a life sciences company focused on early cancer detection, is planning on raising over $1 billion in Series B funding, according to its parent company Illumina Inc. The investors were not named. Goldman Sachs will serve a a placement agent. GRAIL's previous backers include ARCH Venture Partners, Bezos Expeditions, Bill Gates, Sutter Hill Ventures and GV.
1 min read · 06 January 2017
Vancouver, British Columbia and Bozeman, Montana-based Microbion Corp, a biopharmaceutical company focused on treating antibiotic-resistant infections, has secured $25 million in funding. The investors were Quark Venture Inc and GF Securities.
1 min read · 06 January 2017
Silicon Valley-based Bitglass, a data protection company, has secured $45 million in Series C funding. The investors included Future Fund, New Enterprise Associates, Norwest and SingTel Innov8.
2 min read · 06 January 2017
Digitalis has launched a $100 million fund. Based in New York City and California, Digitalis focuses on companies that address human health challenges.
2 min read · 05 January 2017
Indianapolis-based ClearScholar, a mobile student engagement platform, has raised $1.25 million in funding. The investors included High Alpha Capital, Elevate Ventures, Butler University and Stephen Simon, co-founder of Simon Equity Partners.
1 min read · 05 January 2017
San Diego-based Molecular Stethoscope Inc, a developer of blood-based early detection and disease monitoring tests, has closed $8.2 million seed financing. The investors included Data Collective, Pfizer Inc and Index Ventures.
1 min read · 05 January 2017
La Jolla, California-based Avidity Biosciences, a biotech company, has raised $16 million in Series B financing. Takeda Pharmaceuticals led the round with participation from other investors that included Alethea Capital, Alexandria Real Estate Equities, Brace Pharma, EcoR1 Capital, F-Prime Capital, Moore Venture Partners and Tavistock Life Sciences.
1 min read · 05 January 2017
New York-based Namely, an HR platform, has secured $50 million in funding, according to a blog post on its site. Altimeter Capital and Scale Venture Partners led the round with participation from Sequoia Capital, Matrix Partners, True Ventures, Greenspring and Four Rivers.
1 min read · 05 January 2017
Cambridge, Massachusetts-based Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, has closed $70 million in Series B financing. Partner Fund Management led the round with participation from Third Rock Ventures, Access Industries, Fidelity Management & Research Company, Wellington Management Company, Inbio Ventures and Nextech Invest.
1 min read · 05 January 2017
